価格表

在庫・価格 : 2025年04月28日 17時18分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
HGF, Human, Recombinant <Hepatocyte Growth Factor>
データシート
294-HGN-025 RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥121,000
(発注済)
追加

在庫・価格 : 2025年04月28日 17時18分 現在

HGF, Human, Recombinant <Hepatocyte Growth Factor>

  • 商品コード:294-HGN-025
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥121,000
  • 在庫:無(発注済)
使用文献
No. 文献情報 備考 参照
1 Barbour AP et al. Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3. Cancer Res. 2003 Feb;63(4):887-92
Barbour AP et al
2003/01/01
Application: Binding Assay, Sample Type: Whole Cells PubMed
2 Lee OK et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004 Mar;103(5):1669-75
Lee OK et al
2004/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
3 Jin M et al. Hepatocyte growth factor and its role in the pathogenesis of retinal detachment. Invest. Ophthalmol. Vis. Sci. 2004 Jan;45(1):323-9
Jin M et al
2004/01/01
Application: In Vivo PubMed
4 Fang B et al. Multipotency of Flk1CD34 progenitors derived from human fetal bone marrow. J. Lab. Clin. Med. 2004 Apr;143(4):230-40
Fang B et al
2004/01/01
Species: Human, Application: Bioassay, Sample type: Whole Cells PubMed
5 Grant-Tschudy KS et al. Hepatocyte growth factor regulation of uterine epithelial cell transepithelial resistance and tumor necrosis factor alpha release in culture. Biol. Reprod. 2005 Apr;72(4):814-21
Grant-Tschudy KS et al
2005/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
6 Gonzalez RM et al. Development and validation of sandwich ELISA microarrays with minimal assay interference. J. Proteome Res. 2008 Jun;7(6):2406-14
Gonzalez RM et al
2008/01/01
Application: ELISA Standard, Sample Type: N/A PubMed
7 Rosov叩 I et al. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 2008 Aug;26(8):2173-82
Rosov叩 I et al
2008/01/01
Species: Human, Application: Bioassay, Whole Cells PubMed
8 Brookes K et al. Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs. Br. J. Cancer 2010 May;102(10):1524-32
Brookes K et al
2010/01/01
Application: Other: See notes, Sample Type: Plasma (EDTA) PubMed
9 Roelandt P et al. Human embryonic and rat adult stem cells with primitive endoderm-like phenotype can be fated to definitive endoderm, and finally hepatocyte-like cells. PLoS ONE 2010;5(8):e12101
Roelandt P et al
2010/01/01
Application: Expansion/Differentiation, Sample Type: Whole Cells PubMed
10 Basilico C et al. Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET. Clin. Cancer Res. 2013 May;19(9):2381-92
Basilico C et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
11 Tervonen TA et al. Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion. Oncogene 2015 Jul;
Tervonen TA et al
2015/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
12 Wang J et al. Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification. BMC Cancer 2016;16(1):105
Wang J et al
2016/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
13 He H et al. Inhibition of Proliferation and Epithelial Mesenchymal Transition in Retinal Pigment Epithelial Cells by Heavy Chain-Hyaluronan/Pentraxin 3. Sci Rep 2017 Mar;7:43736
He H et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Barbour AP et al. Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3. Cancer Res. 2003 Feb;63(4):887-92
    Barbour AP et al
    2003/01/01
  • 備考:
    Application: Binding Assay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Lee OK et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004 Mar;103(5):1669-75
    Lee OK et al
    2004/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Jin M et al. Hepatocyte growth factor and its role in the pathogenesis of retinal detachment. Invest. Ophthalmol. Vis. Sci. 2004 Jan;45(1):323-9
    Jin M et al
    2004/01/01
  • 備考:
    Application: In Vivo
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Fang B et al. Multipotency of Flk1CD34 progenitors derived from human fetal bone marrow. J. Lab. Clin. Med. 2004 Apr;143(4):230-40
    Fang B et al
    2004/01/01
  • 備考:
    Species: Human, Application: Bioassay, Sample type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Grant-Tschudy KS et al. Hepatocyte growth factor regulation of uterine epithelial cell transepithelial resistance and tumor necrosis factor alpha release in culture. Biol. Reprod. 2005 Apr;72(4):814-21
    Grant-Tschudy KS et al
    2005/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Gonzalez RM et al. Development and validation of sandwich ELISA microarrays with minimal assay interference. J. Proteome Res. 2008 Jun;7(6):2406-14
    Gonzalez RM et al
    2008/01/01
  • 備考:
    Application: ELISA Standard, Sample Type: N/A
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Rosov叩 I et al. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 2008 Aug;26(8):2173-82
    Rosov叩 I et al
    2008/01/01
  • 備考:
    Species: Human, Application: Bioassay, Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Brookes K et al. Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs. Br. J. Cancer 2010 May;102(10):1524-32
    Brookes K et al
    2010/01/01
  • 備考:
    Application: Other: See notes, Sample Type: Plasma (EDTA)
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Roelandt P et al. Human embryonic and rat adult stem cells with primitive endoderm-like phenotype can be fated to definitive endoderm, and finally hepatocyte-like cells. PLoS ONE 2010;5(8):e12101
    Roelandt P et al
    2010/01/01
  • 備考:
    Application: Expansion/Differentiation, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Basilico C et al. Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET. Clin. Cancer Res. 2013 May;19(9):2381-92
    Basilico C et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Tervonen TA et al. Deregulated hepsin protease activity confers oncogenicity by concomitantly augmenting HGF/MET signalling and disrupting epithelial cohesion. Oncogene 2015 Jul;
    Tervonen TA et al
    2015/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Wang J et al. Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification. BMC Cancer 2016;16(1):105
    Wang J et al
    2016/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    He H et al. Inhibition of Proliferation and Epithelial Mesenchymal Transition in Retinal Pigment Epithelial Cells by Heavy Chain-Hyaluronan/Pentraxin 3. Sci Rep 2017 Mar;7:43736
    He H et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed